NCT06112119

Role of MSCT Volumetry in Assessment of Brain Atrophy in Septic Patients

Role of Semi-automatic MSCT Volumetry in Assessment of Rapidly Progressive Brain Atrophy in Septic ICU Patients.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 55 (estimated)
• Sponsor: Assiut University · Academic / Other
• Sex: All
• Age: 16 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

assessment of brain atrophy associated with septic ICU patients by using MSCT Volumetry

Detailed description

Sepsis is the leading cause of admission to ICU , the number of patients who survive and discharge from ICU has also increased due to technological advances in ICU however quality of life of these patients after ICU discharge is lower than that of healthy people of a similar age, in particular Sepsis associated encephalopathy associated with brain dysfunction. We hypothesized that brain damage including brain volume reduction that ocurre in acute phase of Sepsis using CT scan and there finding " relationship to risk factor and outcome". We compared head CT finding at time of admission with those obtained during the course of the treatment

Conditions

• Sepsis-Associated Encephalopathy

Interventions

Type	Name	Description
DEVICE	MSCT	Using Semi-automatic MSCT Volumetry in assessment of brain atrophy associated with septic ICU patients

Timeline

• Start date: 2023-11-01
• Primary completion: 2024-11-01
• Completion: 2024-12-30
• First posted: 2023-11-01
• Last updated: 2023-11-01

Regulatory

• FDA-regulated device study